Bioli’s Skincare Testing Program
January, 2026
Bioli is now inviting participants to take part in a larger skincare testing study, facilitated by our scientific team, to support advances in long-term facial skin health.
How participation works
Participants will test one Bioli facial skincare product over an 8-week period. During the study, participants will complete three short online questionnaires (approximately 10 minutes each):
-
At the beginning of the study
-
Halfway through the 8-week period
-
At the end of the study
The questionnaires help us understand skin condition, product experience, and changes over time.
Why participate
With millions of people worldwide affected by skin disorders, Bioli’s mission is to improve and maintain long-term skin health through effective biotech-based products with a low environmental impact.
We are currently receiving feedback—particularly from people with rosacea, children and adults with eczema, and individuals experiencing skin flare-ups due to chemotherapy—that our products calm the skin, are non-itching, and feel more soothing than other products. We are now looking to conduct a larger, exploratory study. The results will support continued product development.
Who can join
We welcome individuals with normal facial skin, and are particularly interested in those with sensitive facial skin or facial skin conditions such as acne, perioral dermatitis, eczema, psoriasis, rosacea, skin issues related to cancer, or similar concerns.
Eligibility:
-
People of all ethnicities, with normal or sensitive facial skin
-
Based in Europe
-
Men and women of all ages
-
Children may participate with a parent or guardian
How to join
If you are interested, please complete this short 1-minute form with basic information about your age, gender, and skin type. We will review all submissions and select a diverse group of participants.
If selected, you will receive a follow-up survey, and the facial skincare product by mail. Study results will be shared with participants who choose to receive them.
